SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-027516
Filing Date
2019-07-31
Accepted
2019-07-31 16:31:33
Documents
72
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-10q_20190630.htm 10-Q 1808953
2 EX-31.1 vtvt-ex311_9.htm EX-31.1 17634
3 EX-31.2 vtvt-ex312_8.htm EX-31.2 17526
4 EX-32.1 vtvt-ex321_6.htm EX-32.1 7263
5 EX-32.2 vtvt-ex322_7.htm EX-32.2 7218
6 GRAPHIC g02dvb5v1244000001.jpg GRAPHIC 29313
  Complete submission text file 0001564590-19-027516.txt   6600786

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vtvt-20190630.xml EX-101.INS 1323409
8 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20190630.xsd EX-101.SCH 60362
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20190630_cal.xml EX-101.CAL 42133
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20190630_def.xml EX-101.DEF 245644
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20190630_lab.xml EX-101.LAB 424412
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20190630_pre.xml EX-101.PRE 336120
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 19989189
SIC: 2834 Pharmaceutical Preparations